The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pneumonitis in non-small cell lung cancer (NSCLC) patients treated with programmed death 1 (PD1) axis inhibitors.
 
Scott N. Gettinger
Consulting or Advisory Role - ARIAD; Bristol-Myers Squibb; Janssen
Research Funding - ARIAD (Inst); AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Incyte (Inst); Pfizer (Inst)
 
Xuchen Zhang
No Relationships to Disclose
 
Robert Homer
Honoraria - Boehringer Ingelheim
Speakers' Bureau - Boehringer Ingelheim
 
Jennifer Possick
No Relationships to Disclose
 
Anna Wurtz
No Relationships to Disclose
 
Sarah B. Goldberg
Consulting or Advisory Role - Clovis Oncology
Research Funding - AstraZeneca; Genentech (Inst); Immunogen (Inst); Kadmon (Inst); Merck (Inst)
 
Anne C. Chiang
Consulting or Advisory Role - Genentech; Genentech/Roche
Research Funding - Boehringer Ingelheim; Millennium; OncoMed; Onyx
 
Roy S. Herbst
Honoraria - AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech/Roche; Lilly; Merck; NovaRX; pfizer
Consulting or Advisory Role - Biothera; DiaTech Oncology; Endocyte; Kolltan Pharmaceuticals; N-of-One
Research Funding - Genentech/Roche
 
Ami Rubinowitz
No Relationships to Disclose